Healthcare entity
Of the tracked stories, 1 of 2 also mention BioNEST, the most common co-covered peer. At 7.5, the average consequence score sits above the same-window beat average of 6.1. funding accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder.
Last mentioned: Mar 20, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention BioNEST, the most common co-covered peer. At 7.5, the average consequence score sits above the same-window beat average of 6.1. funding accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. They are corroborated in line with the beat average, carrying 3 original sources each against 3 for the same window. We currently track 2 Healthcare stories that mention Department of Biotechnology (DBT), published between March 20, 2026 and March 22, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 56 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Department of Biotechnology (DBT). Shared-story counts are live from our verified record — not editorial picks.
Bio-Economy Target
India aims for a $300 billion bio-economy valuation.
Strategic Recognition
Minister Jitendra Singh formally identifies the sector boom as a shift to strategic self-reliance.
14th Foundation Day
Celebration of 15 years of biotech development and ₹4,200 crore funding milestone.
Import Substitution Milestone
Significant reduction in the trade deficit for essential medical consumables reported.
National Medical Device Policy
Cabinet approves a comprehensive policy to facilitate orderly growth of the MedTech sector.
PLI Scheme Launch
Government introduces Production Linked Incentives for Pharmaceuticals and Medical Devices.
BIRAC Inception
Established as a Public Sector Enterprise by the Department of Biotechnology.
Ecosystem Expansion
Launch of BIG, BioNEST, and National Biopharma Mission programs.
Union Minister Jitendra Singh has highlighted a transformative boom in India's pharmaceutical and medical technology sectors, marking a decisive shift toward national self-sufficiency. This growth, fueled by policy reforms and domestic innovation, positions India to reduce its historical dependence on healthcare imports while expanding its global manufacturing footprint.
Source: news.webindia123.com · newkerala.com
The Biotechnology Industry Research Assistance Council (BIRAC) celebrated its 14th Foundation Day, announcing ₹4,200 crore in total funding enabled for over 15 lakh startups and entrepreneurs. This massive deployment of capital and infrastructure marks a pivotal moment in India's journey toward a $300 billion bio-economy by 2030.
Department of Biotechnology (DBT) is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
